Making sense of desensitization.
Several questions must be addressed to determine whether desensitization plus paired exchange is an appropriate strategy for renal transplantation.
H M
HM
Gebel
P F
PF
Halloran
D000017:ABO Blood-Group System; D001787:Blood Group Incompatibility; D003888:Desensitization, Immunologic / Q000379:methods*; D006680:HLA Antigens / Q000378:metabolism; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000378:metabolism / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007674:Kidney Diseases / Q000473:pathology / Q000628:therapy; D016030:Kidney Transplantation / Q000009:adverse effects*; D008214:Lymphocytes / Q000166:cytology; D012306:Risk
D000017:ABO Blood-Group System; D006680:HLA Antigens; D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents